LGND Operating Cash Flow (Statement)
Ligand Pharmaceuticals Inc · Operating Cash Flow (Statement)
LGND Operating Cash Flow (Statement)
Latest reported$131.64Mperiod ending
LGND Cash from Operations (-$14.30M → $131.64M)
Annual operating cash flow (statement)
High-resolution chart · PNG
LGND operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 49,359,000 | |
| 97,047,000 | |
| 49,577,000 | |
| 137,850,000 | |
| 78,798,000 | |
| 54,586,000 | |
| -29,336,000 | |
| 194,059,000 | |
| 93,568,000 | |
| 63,001,000 | |
| 41,727,000 | |
| 20,566,000 | |
| 20,690,000 | |
| 161,000 | |
| -1,172,000 | |
| -27,067,000 | |
| -33,801,000 | |
| -20,625,000 | |
| -97,727,000 | |
| -138,521,000 | |
| 8,365,000 | |
| 5,754,000 | |
| 274,000 | |
| -25,112,000 | |
| -19,906,000 | |
| -47,355,000 | |
| -60,500,000 | |
| -66,600,000 | |
| -13,400,000 | |
| -33,300,000 | |
| -37,900,000 | |
| -14,300,000 |